Article No. 387
13 October 2020
This website has featured several articles* about the topic of aHUS Transplants and their need for eculizumab support. These articles have provided some of the answers about whether eculizumab is needed to avoid a re-onset of aHUS when triggered by the transplant, and whether eculizumab should be given before or after the transplant operation.
We know now that not all transplants need eculizumab, but , if they do, they should be supported before the operation rather than after it for the bests results i.e. the quality of kidney function and longevity of the kidney graft. Information is also now emerging about whether, and when, eculizumab treatment can be withdrawn. It can in some cases, at some point in time.
This summer an article was published by Dr Anuja Java about managing aHUS transplants (click HERE to see the abstract). It was accompanied by an infographic which summarises , in a simple way, what has been learned about aHUS transplants in the past few years. The original has been cropped and enlarged for website resolution purposes and is presented below in five images
– overview of aHUS
– pre-transplant evaluation
– donor selection and peri-operative management
-recurrence risk evaluation –
duration of therapy.
The original complete infographic